Rockwell Medical (RMTI) Cash from Investing Activities (2010 - 2026)

Rockwell Medical has reported Cash from Investing Activities for 17 years, with the latest figure at -$122000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 12100.0% year-over-year to -$122000.0; the trailing twelve-month figure through Mar 2026 stood at -$8.7 million (down 83.27% YoY), and the FY2025 full-year result was -$8.5 million, down 75.59% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$122000.0, up from -$4.1 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $9.1 million in Q1 2022, with the low at -$14.7 million in Q3 2022.
• Historically, Cash from Investing Activities has averaged -$1.1 million across 5 years, with a median of -$103000.0 in 2025.
• Annual changes were most pronounced in 2024 — Cash from Investing Activities soared 2782.81% — and 2026, when it sank 12100.0%.
• Rockwell Medical's Cash from Investing Activities stood at $3.2 million in 2022, then plunged by 37.6% to $2.0 million in 2023, then slumped by 116.53% to -$332000.0 in 2024, then sank by 1144.28% to -$4.1 million in 2025, then surged by 97.05% to -$122000.0 in 2026.
• The last three Cash from Investing Activities figures came in at -$122000.0 (Q1 2026), -$4.1 million (Q4 2025), and -$4.3 million (Q3 2025), per Business Quant data.